These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 7897376)
21. Clinical trial to evaluate immunogenicity and safety of inactivated hepatitis A vaccination starting at 2-month-old children. Kanra G; Yalçin SS; Ceyhan M; Yurdakök K Turk J Pediatr; 2000; 42(2):105-8. PubMed ID: 10936974 [TBL] [Abstract][Full Text] [Related]
22. Clinical assessment of the safety and efficacy of an inactivated hepatitis A vaccine: rationale and summary of findings. André FE; D'Hondt E; Delem A; Safary A Vaccine; 1992; 10 Suppl 1():S160-8. PubMed ID: 1335652 [TBL] [Abstract][Full Text] [Related]
23. Hepatitis A vaccine. A new convenient single-dose schedule with booster when long-term immunization is warranted. Victor J; Knudsen JD; Nielsen LP; Fomsgaard A; Thybo S; Bygbjerg I; Westh H Vaccine; 1994 Nov; 12(14):1327-9. PubMed ID: 7856299 [TBL] [Abstract][Full Text] [Related]
24. [The study on the 0, 12 month vaccination schedule' of Healive inactivated hepatitis A vaccine in children]. Ren YH; Chen JT; Wu WT; Gong XJ; Zhang YC; Xue WH; Ren YF; Han LJ; Kang WX; Li SP; Liu CB Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Nov; 24(11):1013-5. PubMed ID: 14687502 [TBL] [Abstract][Full Text] [Related]
25. Hepatitis A vaccination by intracutaneous low dose administration: a less expensive alternative. Carlsson U; Brudin L; Eliasson I; Hansson BG Scand J Infect Dis; 1996; 28(5):435-8. PubMed ID: 8953668 [TBL] [Abstract][Full Text] [Related]
26. Comparison of the reactogenicity and immunogenicity of two different dose levels of hepatitis A vaccine in healthy children and adolescents. Poovorawan Y; Kosuwon P; Sutra S; Theamboonlers A; Vimolket T; Safary A Asian Pac J Allergy Immunol; 1998; 16(2-3):111-7. PubMed ID: 9876949 [TBL] [Abstract][Full Text] [Related]
27. Immunogenicity, safety, and interchangeability of two inactivated hepatitis A vaccines in Chilean children. Abarca K; Ibánez I; Perret C; Vial P; Zinsou JA Int J Infect Dis; 2008 May; 12(3):270-7. PubMed ID: 17988917 [TBL] [Abstract][Full Text] [Related]
29. Immunogenicity of an inactivated hepatitis A pediatric vaccine: three-year post-booster follow-up. Dagan R; Greenberg D; Weber F Vaccine; 2005 Oct; 23(44):5144-8. PubMed ID: 16043271 [TBL] [Abstract][Full Text] [Related]
30. Mathematical models for assessment of long-term persistence of antibodies after vaccination with two inactivated hepatitis A vaccines. Van Herck K; Beutels P; Van Damme P; Beutels M; Van den Dries J; Briantais P; Vidor E J Med Virol; 2000 Jan; 60(1):1-7. PubMed ID: 10568755 [TBL] [Abstract][Full Text] [Related]
31. Clinical and immunological investigation of a new combined hepatitis A and hepatitis B vaccine. Ambrosch F; Wiedermann G; André FE; Delem A; Gregor H; Hofmann H; D'Hondt E; Kundi M; Wynen J; Kunz C J Med Virol; 1994 Dec; 44(4):452-6. PubMed ID: 7897380 [TBL] [Abstract][Full Text] [Related]
32. Immunogenicity of an inactivated hepatitis A vaccine administered according to two different schedules and the interference of other "travellers" vaccines with the immune response. Bienzle U; Bock HL; Kruppenbacher JP; Hofmann F; Vogel GE; Clemens R Vaccine; 1996 Apr; 14(6):501-5. PubMed ID: 8782347 [TBL] [Abstract][Full Text] [Related]
33. Immunogenicity and safety of an inactivated hepatitis A vaccine in Taiwanese adults and children. Lee CY; Huang LM; Lee PI; Chiu HH; Dumas R; Milcamps B; Lin W Southeast Asian J Trop Med Public Health; 2000 Mar; 31(1):29-36. PubMed ID: 11023061 [TBL] [Abstract][Full Text] [Related]
34. Immunogenicity of booster vaccination with a virosomal hepatitis A vaccine after primary immunization with an aluminum-adsorbed hepatitis A vaccine. Beck BR; Hatz CF; Loutan L; Steffen R J Travel Med; 2004; 11(4):201-6. PubMed ID: 15541221 [TBL] [Abstract][Full Text] [Related]
35. [Vaccination against viral hepatitis A and B in adults aged over 40 years--antibody persistence and immune memory]. Chlibek R; Smetana J; Bostíková V; Splino M Epidemiol Mikrobiol Imunol; 2011 Sep; 60(3):99-108. PubMed ID: 22132651 [TBL] [Abstract][Full Text] [Related]
36. Efficacy of an inactivated hepatitis A vaccine in pre- and postexposure conditions in marmosets. D'Hondt E; Purcell RH; Emerson SU; Wong DC; Shapiro M; Govindarajan S J Infect Dis; 1995 Mar; 171 Suppl 1():S40-3. PubMed ID: 7876647 [TBL] [Abstract][Full Text] [Related]
37. Immunogenicity of inactivated hepatitis A vaccine in children. Lee SD; Lo KJ; Chan CY; Yu MY; Wang YJ; Safary A Gastroenterology; 1993 Apr; 104(4):1129-32. PubMed ID: 8462802 [TBL] [Abstract][Full Text] [Related]
38. Does immunoglobulin interfere with the immunogenicity to Pasteur Mérieux inactivated hepatitis A vaccine? Zanetti A; Pregliasco F; Andreassi A; Pozzi A; Viganò P; Cargnel A; Briantais P; Vidor E J Hepatol; 1997 Jan; 26(1):25-30. PubMed ID: 9148018 [TBL] [Abstract][Full Text] [Related]
39. [Reactivity and immunogenicity of Havrix 360 vaccine for hepatitis A]. Borcić B; Kovac S; Mihaljević I; Dobrovsak-Sourek V; Ljubicić M Lijec Vjesn; 1996; 118(7-8):162-4. PubMed ID: 8965633 [TBL] [Abstract][Full Text] [Related]
40. A single vaccination with an inactivated hepatitis A liposome vaccine induces protective antibodies after only two weeks. Just M; Berger R; Dreschsler H; Brantschen S; Glück R Vaccine; 1992; 10(11):737-9. PubMed ID: 1441728 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]